470463-34-4 Usage
General Description
2-(2,2-Dimethyl-propionylamino)-isonicotinic acid is a chemical compound categorized under the broad group of organic compounds. It is composed of multiple functional groups including a carboxylic acid group, an amino group, and an aromatic ring motif. The 2,2-dimethyl-propionylamino part of the compound suggests that it is a substituted amide, containing a tertiary carbon. 2-(2,2-Dimethyl-propionylamino)-isonicotinic acid has potential applications in several areas due to its structural complexity and versatile functional groups. However, the specific properties, toxicity, and reactions of this chemical are not widely documented, indicating that it may be a relatively lesser-known or less-studied compound in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 470463-34-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,0,4,6 and 3 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 470463-34:
(8*4)+(7*7)+(6*0)+(5*4)+(4*6)+(3*3)+(2*3)+(1*4)=144
144 % 10 = 4
So 470463-34-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N2O3/c1-11(2,3)10(16)13-8-6-7(9(14)15)4-5-12-8/h4-6H,1-3H3,(H,14,15)(H,12,13,16)
470463-34-4Relevant articles and documents
HETEROCYCLIC DERIVATIVES AS Nav1.7 and Nav1.8 BLOCKERS
-
Paragraph 0216; 0244, (2020/07/15)
The present invention relates to heterocyclic derivatives which have blocking activities of voltage gated sodium channels as the Nav1.7 and Nav1.8 channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gat
ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS
-
Page/Page column 216, (2012/05/05)
The present invention relates to arylamide derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.
